# Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

> **NCT01090336** · — · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 26 (estimated)

## Conditions studied

- Patients With Acute Coronary Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01090336
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** —
- **Final completion:** 2011-12
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2011-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01090336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01090336, "Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01090336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
